PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21183736-3	2011	METHODS AND RESULTS: Manipulation of iron status with ferric ammonium citrate and hepcidin-25 induced monocyte chemoattractant protein (MCP)-1 and interleukin-6 in human differentiating monocytes of patients with hyperferritinemia associated with the metabolic syndrome (n=11), but not in subjects with hemochromatosis or HFE mutations impairing iron accumulation (n=15), and the degree of induction correlated with the presence of carotid plaques, detected by echocolor-Doppler.	ferric ammonium citrate	54-77	C-C motif chemokine ligand 2	Homo sapiens	102-142	
19228389-6	2009	The influence of cellular iron secretion on the potent chemokine monocyte chemoattractant protein-1 (MCP-1) was assessed using ferric ammonium citrate and the iron chelator, desferroxamine.	ferric ammonium citrate	127-150	C-C motif chemokine ligand 2	Homo sapiens	65-99	
19228389-6	2009	The influence of cellular iron secretion on the potent chemokine monocyte chemoattractant protein-1 (MCP-1) was assessed using ferric ammonium citrate and the iron chelator, desferroxamine.	ferric ammonium citrate	127-150	C-C motif chemokine ligand 2	Homo sapiens	101-106	
30835899-4	2019	Treatment with iron (ferric ammonium citrate, FAC) led to increased expression levels of M1 markers: CCL2, CD14, iNOS, IL-1beta, IL-6, and TNF-alpha; it also increased protein levels of CD68, TNF-alpha, IL-1beta, and IL-6 by flow cytometry.	ferric ammonium citrate	21-44	C-C motif chemokine ligand 2	Homo sapiens	101-105